Capital Community College's vision is to instill life-changing knowledge in a community of learners from multicultural backgrounds in a vital urban setting where business, culture and government converge. This is a forum that presents news and information about training in Biotechnology at Capital .
Labels
- COMPANIES (7)
- COURSES (7)
- Inquiry Exercises (11)
- JOBS (8)
- METHODS (13)
- NEWS (35)
- STUDENT FORUM (2)
Showing posts with label NEWS. Show all posts
Showing posts with label NEWS. Show all posts
Monday, March 3, 2014
A Human mutation that prevents Diabetes
Investigators at Amgen, Pfizer and DeCODE have discovered a mutation in a zinc transporter that appears to prevent the onset of Diabetes. This will likely have significant therapeutic interest.
Sunday, February 23, 2014
Scientists Transform Skin Cells into Functioning Liver Cells
In our intro Biotechnology course , there has been considerable interest in generating reagents useful for the development of functional liver cells. In this report, investigators at the Gladstone Institute report success in transforming human skin cells into functioning liver cells.
Friday, February 21, 2014
MIT’s Synthetic Biology Center collaborates with Pfizer to advance synthetic biology research in drug discovery and development
An interesting article that discusses the significant move in Pharma to go back to Biotechnology basics.
Tuesday, January 14, 2014
Alexion increasing Drug Portfolio
Alexion Pharmaceuticals, buys new drug therapies from Moderna Therapeutics
Monday, October 28, 2013
Amylase becomes a celebrity ?
Many think that having a sense of humor is key to developing a critical sense in science. This feature from ONION , the well known satirical web site offers a humorous opportunity !
Tuesday, September 17, 2013
Tales from the Genome ? 23and Me and Udacity
23 and Me, the premier personal genomics company has set up a collaboration with Udacity to offer an online genomics course . The course will integrate student observations on their own genome with discussion on the likely function of DNA sequence variants.
Thursday, September 12, 2013
The Top Ten List of Sequencing Techniques
The journal Biotechniques has compiled a list of the top ten sequencing techniques complete with downloadable pdfs .
Free fellowships to develop web skills
A pioneering program in NYC offers free fellowships to adults who have not had any previous training in web development technologies .
Wednesday, September 4, 2013
State's Quest To Be 'On The Bioscience Map' Progresses
Governor Malloy is scheduled to sign the Bioscience Innovation Act which will provide funding to enable new biotechnology collaborations between universities and small companies in CT.
Monday, August 5, 2013
Low GC content makes B. braunii good candidate for biofuel production.
An article in Phycologia suggests B. braunii is an attractive algae for bio fuel production.
Friday, July 26, 2013
Bridging the Gap Between Undergraduate Education and Research
An interesting student article on Science Education.
"Undergraduate science education is changing. Fading are the days of large introductory lectures, where faceless students are merely consumers of certain knowledge to be later regurgitated on an exam. That model of teaching might get the information across, but it fails to engage students. Where the infamous ‘weed-out’ courses do succeed, however, is in depleting the science talent pool: only 40% of students intending to major in a STEM discipline actually graduate with that major. "
"Undergraduate science education is changing. Fading are the days of large introductory lectures, where faceless students are merely consumers of certain knowledge to be later regurgitated on an exam. That model of teaching might get the information across, but it fails to engage students. Where the infamous ‘weed-out’ courses do succeed, however, is in depleting the science talent pool: only 40% of students intending to major in a STEM discipline actually graduate with that major. "
Friday, July 19, 2013
Loss of Function of the Melanocortin 2 Receptor Accessory Protein 2 Is Associated with Mammalian Obesity
Studies in mice indicated that loss of function of the Melanocortin 2 Receptor Accessory Protein 2 increased obesity. The investigators then looked at human subjects and found that mutations in this gene were associated with human obesity.
Thursday, July 18, 2013
3D print your favorite protein !
It is often difficult to appreciate the nuances of protein structure by viewing a spinning image on a monitor. Being able to look at a solid model, often reveals major insights. In this blog article , a simple step by step protocol is presented that enables students to create a 3D model of their favorite protein. All you need is a 3D printer !
Thursday, June 27, 2013
Implications of Biotechnology and Genomics for Nursing Practice
Next generation DNA sequencing strategies
Dr. Mardis, one of the pioneers in using next generation sequencing strategies to understand human disease, talks about recent developments.
The Million Mutation Project: A new approach to genetics in Caenorhabditis elegans
This is an interesting resource paper. The investigators have generated a library of mutagenized C. Elegans strains. What's new is that each member of the library has been sequence verified to identify mutant alleles that cover all known C. Elegans genes. The paper is from the Waterston lab and is open access.
Tuesday, June 25, 2013
CT's Alexion is one of the Three Best-run Biotechnology Companies in the USA !
Alexion was recently written up as one of the three best-run Biotechnology companies in the USA .
"Alexion's focus on ultra-rare diseases has led to ultra-rare results. The biotech achieved a 15.1% ROIC over the past year. Its five-year average of 21.6% is even better.
Earnings growth has been stellar. Alexion's net income over a trailing 12-month window increased 49% during the last year. Over the past five years, Alexion saw earnings skyrocket by more than 460%.
The company's CEO, Dr. Leonard Bell, helped develop Soliris, which treats the rare diseases paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Bell co-founded Alexion in 1992 and led the company through its IPO four years later. He also was instrumental in Alexion gaining regulatory approval for Soliris and successfully launching the drug. Along the way, Alexion has received several honors, including being named the world's second-most innovative company by Forbes in 2012. "
"Alexion's focus on ultra-rare diseases has led to ultra-rare results. The biotech achieved a 15.1% ROIC over the past year. Its five-year average of 21.6% is even better.
Earnings growth has been stellar. Alexion's net income over a trailing 12-month window increased 49% during the last year. Over the past five years, Alexion saw earnings skyrocket by more than 460%.
The company's CEO, Dr. Leonard Bell, helped develop Soliris, which treats the rare diseases paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Bell co-founded Alexion in 1992 and led the company through its IPO four years later. He also was instrumental in Alexion gaining regulatory approval for Soliris and successfully launching the drug. Along the way, Alexion has received several honors, including being named the world's second-most innovative company by Forbes in 2012. "
Monday, June 24, 2013
The Origin of GENENTECH
A very interesting reflection on GENENTECH, one of the original Biotechnology companies.
Jobs in Academic Research Labs
Biotechnology graduates typically look for jobs with large Biotechnology companies and are generally unaware of the excellent career development possibilities presented by small academic research labs. In small academic research labs, there is often a more significant focus on discovering new technologies that are yet to be found in mainstream Biotechnology. Thus, employment in an academic research lab often significantly enhances the career trajectory of Biotechnologists. In this post , we report the recent round of Stem Cell funding in CT, which will likely have the effect of increasing the number of entry level positions in academic Biotechnology labs.
"Nine scientists at the University of Connecticut Health Center received grant awards Monday totaling $4.5 million from the Connecticut Stem Cell Research Program, making UConn the largest recipient of the $9.8 million total grants awarded this year."
"Nine scientists at the University of Connecticut Health Center received grant awards Monday totaling $4.5 million from the Connecticut Stem Cell Research Program, making UConn the largest recipient of the $9.8 million total grants awarded this year."
CT Innovations funds new Biotech Companies
CT Innovations awarded start-up funds totaling $560k to four new Biotech companies in the Hartford area.
Subscribe to:
Posts (Atom)